Literature DB >> 7798546

Total serum IgE and eosinophil count in children with and without a history of asthma, wheezing, or atopy in an urban community in Indonesia. The Respiratory Disease Working Group.

C B Kartasamita1, O Rosmayudi, M Demedts.   

Abstract

AIM: The objectives of the study were to assess total serum IgE and eosinophil count in a random sample of 20% of the children between 12 and 54 months old in a suburban community of Bandung, Indonesia, and to investigate a possible relationship between these values and atopy, asthma or wheezing and parasite infestation.
METHODS: Two hundred sixty-nine children were examined at the Integrated Primary Health Care Unit, and the parents or guardians were interviewed with the use of a standardized questionnaire.
RESULTS: The overall median value of IgE was 436 IU/ml (range, 18 to 9707 IU/ml); almost 94% of the children showed an IgE value of more than 100 IU/ml, and 29% showed a value of more than 1000 IU/ml. The median value for eosinophils was 580/mm3 (range, 70 to 5090/mm3); only 31% of the children had less than 400 eosinophils/mm3. IgE levels and eosinophilia were not related to age but showed a significant, although not high, correlation with each other (p < 0.05). In about 36% of the children parasites were demonstrated in a single stool sample; in those subjects eosinophilia and IgE values tended to be greater, but the difference was not significant. About 7% of the children had asthma, and in those subjects the eosinophil counts and IgE levels were much more increased (p < 0.001 and p approximately 0.01, respectively). No difference was found in IgE or eosinophil count in relation to other forms of atopy in the child (milk-induced dermatitis, urticaria, eczema, rhinitis) or in relation to a history of asthma or atopy in other family members. Yet, the occurrence of asthma in the child was significantly related to a history of asthma in other family members.
CONCLUSIONS: IgE values and eosinophilia are markedly increased in these children under 5 years of age in Bandung, Indonesia, and the highest values are found in the 7% with asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798546     DOI: 10.1016/0091-6749(94)90116-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children.

Authors:  P A Steerenberg; N A H Janssen; G de Meer; P H Fischer; S Nierkens; H van Loveren; A Opperhuizen; B Brunekreef; J G C van Amsterdam
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

2.  Immunoglobulin isotypes in childhood asthma.

Authors:  F I Najam; A S Giasuddin; A H Shembesh
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

3.  The impact of environmental and agricultural pollutants on the prevalence of allergic diseases in people from Qassim, KSA.

Authors:  Walaa Othman Elshabrawy; Hisham Abdel-Sadek Ismail; Khaled Mohamed Hassanein
Journal:  Int J Health Sci (Qassim)       Date:  2014-01

4.  Atopy is a risk factor for adult asthma in urban community of Southwestern Nigeria.

Authors:  O M Ige; A G Falade; O G Arinola
Journal:  Lung India       Date:  2012-04

5.  Correlation of total serum immunoglobulin E level, sputum, and peripheral eosinophil count in assessing the clinical severity in bronchial asthma.

Authors:  Roshan M Kumar; R Pajanivel; G Koteeswaran; Surendra K Menon; Pravin Mv Charles
Journal:  Lung India       Date:  2017 May-Jun

6.  Specific IgE Anti-Ascaris in Brazilian Children and Adolescents.

Authors:  Emanuel S Sarinho; Décio Medeiros; Almerinda Silva; José Angelo Rizzo
Journal:  World Allergy Organ J       Date:  2010-03       Impact factor: 4.084

7.  Blood eosinophils associate with reduced lung function growth in adolescent asthmatics.

Authors:  Hans Jacob L Koefoed; Ulrike Gehring; Judith M Vonk; Gerard H Koppelman
Journal:  Clin Exp Allergy       Date:  2021-01-16       Impact factor: 5.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.